DIG
JAZZ icon

DeepCurrents Investment Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

DeepCurrents Investment Group’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-480
Closed -$7.47M – 236
2022
Q1 		$7.47M Buy
+480
New +$69.7K 0.23% 91

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

DeepCurrents Investment Group's JAZZ Position: Q1 2026 in Review

DeepCurrents Investment Group increased its Jazz Pharmaceuticals (JAZZ) stake by 1.6% in Q1 2026, buying an estimated $201K and bringing the position to 71,636 shares worth $13.5M. The position accounts for 0.43% of the portfolio, ranked #75.

DeepCurrents Investment Group first reported a position in JAZZ in Q4 2018 and has held it in 11 quarters since. The position peaked at $26.3M in Q1 2022. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • DeepCurrents Investment Group held 71,636 shares of Jazz Pharmaceuticals worth $13.5M as of Q1 2026.
  • DeepCurrents Investment Group bought 1,150 Jazz Pharmaceuticals shares in Q1 2026, an estimated $201K.
  • Jazz Pharmaceuticals made up 0.43% of DeepCurrents Investment Group's portfolio in Q1 2026, its #75 holding.
  • DeepCurrents Investment Group first reported a position in Jazz Pharmaceuticals in Q4 2018 and has held it in 11 quarters since.
  • DeepCurrents Investment Group's Jazz Pharmaceuticals position peaked at $26.3M in Q1 2022.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on DeepCurrents Investment Group's 13F filing for Q1 2026, filed 15 May 2026.